Microcap Ledger

Tickers · $RVP

Retractable Technologies Inc $RVP

By Microcap Ledger desk · CIK 0000946563

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
NYSE American
Sector
Surgical & Medical Instruments & Apparatus
Headquarters
Little Elm, TX
Fiscal year end
December 31
Shares outstanding
29,937,159 [10-Q 2026-08-14]
as of 2026-08-01

Sources: [10-K 2026-03-27]

What the company doesAI summary of filing

Retractable Technologies, Inc. manufactures and markets safety medical products, predominantly syringes and needles, for the healthcare industry. The company operates manufacturing facilities in Little Elm, Texas and uses manufacturers in China, and distributes its products throughout the U.S. through distributors and a direct marketing network to healthcare providers. The company is revenue-generating, with syringe sales (under brands VanishPoint®, Patient Safe®, and EasyPoint®) comprising the majority of revenues. The company's products are subject to FDA regulation and international compliance requirements, and faces material headwinds from tariffs on Chinese imports, with prevailing tariff rates on syringes and needles from China at 120% as of March 2026. [10-K 2026-03-27]

Segments: VanishPoint® syringes and needles, EasyPoint® retractable needles, Patient Safe® products

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
6 months to Jun 2026$14.38M−$1.39M −$3.10M$2.64M[10-Q 2026-08-14]
FY ended Dec 2025$38.27M−$12.57M −$7.06M$2.59M[10-K 2026-03-27]
FY ended Dec 2024$33.05M−$11.89M −$11.56M$4.24M[10-K 2026-03-27]
Quarterly cash burn
−$1.55M
Cash runway Estimate
~5.1 months

Estimate: cash at the end of the period (6 months to Jun 2026) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-11-0129,937,159[10-Q 2024-11-14]
2025-03-1029,937,159[10-K 2025-03-28]
2025-05-0129,937,159[10-Q 2025-05-15]
2025-08-0129,937,159[10-Q 2025-08-14]
2025-11-0329,937,159[10-Q 2025-11-14]
2026-03-0929,937,159[10-K 2026-03-27]
2026-05-0129,937,159[10-Q 2026-05-15]
2026-08-0129,937,159[10-Q 2026-08-14]

Listing status

Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2025-11-14Shaw Thomas Jbuy5,731$0.77[4 2025-11-17]
2025-11-11Shaw Thomas Jbuy100$0.81[4 2025-11-13]
2025-11-05Shaw Thomas Jbuy7,500$0.83[4 2025-11-06]
2025-10-30Shaw Thomas Jbuy15,000$0.86[4 2025-10-31]
2025-10-28Shaw Thomas Jbuy35,000$0.92[4 2025-10-29]
2025-10-27Shaw Thomas Jbuy34,506$0.94[4 2025-10-28]
2025-10-23Shaw Thomas Jbuy356$0.95[4 2025-10-27]
2025-10-22Shaw Thomas Jbuy10,000$0.96[4 2025-10-23]

Catalysts and calendar

Recent filings and releases
DateTypeTitle
2026-09-308-KOther events
2026-08-148-KOther events
2026-08-1410-QQuarterly report
2026-06-308-KOther events
2026-05-158-KOther events
2026-05-1510-QQuarterly report
2026-05-138-KShareholder vote results
2026-04-108-KOther events
2026-03-278-KOther events
2026-03-2710-KAnnual report
2026-03-27DEF 14AProxy statement
2025-12-308-KOther events

Facts as of . Small caps move fast; check the latest filings.